The ongoing telmisartan alone and in combination with ramipril global endpoint trial program
- 1 May 2003
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 91 (10) , 28-34
- https://doi.org/10.1016/s0002-9149(03)00230-3
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?The American Journal of Cardiology, 2002
- Angiotensin II and trials of cardiovascular outcomes11Reprints are not available.The American Journal of Cardiology, 2002
- RamiprilDrugs, 2002
- Prognostic Value of Ambulatory Blood PressureHypertension, 2000
- Angiotensin II Type 1 Receptor–Mediated Peroxide Production in Human MacrophagesHypertension, 1999
- Circadian Variation in Acute Ischemic StrokeStroke, 1998
- TelmisartanDrugs, 1998
- Increased onset of sudden cardiac death in the first three hours after awakeningThe American Journal of Cardiology, 1992
- Morning increase in onset of ischemic stroke.Stroke, 1989
- Circadian Variation in the Frequency of Onset of Acute Myocardial InfarctionNew England Journal of Medicine, 1985